PMDA — authorised 23 March 2021
- Marketing authorisation holder: Nihon Medi-Physics Co., Ltd.
- Status: approved
🇯🇵 Axumin in Japan
PMDA authorised Axumin on 23 March 2021
Marketing authorisation
Axumin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Axumin approved in Japan?
Yes. PMDA authorised it on 23 March 2021.
Who is the marketing authorisation holder for Axumin in Japan?
Nihon Medi-Physics Co., Ltd. holds the Japanese marketing authorisation.